Literature DB >> 7182977

Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora.

J F Dobkin, J R Saha, V P Butler, H C Neu, J Lindenbaum.   

Abstract

Digoxin is converted to cardioinactive reduced metabolites (DRP) in vivo and in vitro by the human gut flora. Digoxin inactivation is mediated by Eubacterium lentum, a normal inhabitant of the gastrointestinal flora. E. lentum appears to be the sole organism performing this reaction. Fecal bacteria that convert digoxin to DRP in vitro have been found to be present in some subjects who fail to make DRP in vivo. DRP-forming E. lentum have been isolated from the stools of two such subjects. When increasing amounts of arginine are supplied as a growth substrate to E. lentum, bacterial growth and DRP production vary inversely. Further study will be required to identify the factors which determine why digoxin is inactivated in vivo by the gut flora of certain patients and not by others.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7182977

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


  11 in total

Review 1.  Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?

Authors:  Lingeng Lu; Yixing Wu; Lingjun Zuo; Xingguang Luo; Peter J Large
Journal:  World J Microbiol Biotechnol       Date:  2013-10-09       Impact factor: 3.312

Review 2.  Metagenome-wide association studies: fine-mining the microbiome.

Authors:  Jun Wang; Huijue Jia
Journal:  Nat Rev Microbiol       Date:  2016-07-11       Impact factor: 60.633

Review 3.  Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

Authors:  Ian D Wilson; Jeremy K Nicholson
Journal:  Transl Res       Date:  2016-08-13       Impact factor: 7.012

Review 4.  Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.

Authors:  Marwa ElRakaiby; Bas E Dutilh; Mariam R Rizkallah; Annemarie Boleij; Jason N Cole; Ramy K Aziz
Journal:  OMICS       Date:  2014-05-02

5.  Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora.

Authors:  V I Mathan; J Wiederman; J F Dobkin; J Lindenbaum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

6.  Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum.

Authors:  L W Robertson; A Chandrasekaran; R H Reuning; J Hui; B D Rawal
Journal:  Appl Environ Microbiol       Date:  1986-06       Impact factor: 4.792

7.  Reductive inactivation of digitoxin by Eubacterium lentum cultures.

Authors:  A Chandrasekaran; L W Robertson; R H Reuning
Journal:  Appl Environ Microbiol       Date:  1987-04       Impact factor: 4.792

Review 8.  Moving on from Metchnikoff: thinking about microbiome therapeutics in cancer.

Authors:  Saman Maleki Vareki; Ryan M Chanyi; Kamilah Abdur-Rashid; Liam Brennan; Jeremy P Burton
Journal:  Ecancermedicalscience       Date:  2018-09-05

9.  Manipulation of the Gut Microbiome Alters Acetaminophen Biodisposition in Mice.

Authors:  Michael A Malfatti; Edward A Kuhn; Deepa K Murugesh; Melanie E Mendez; Nicholas Hum; James B Thissen; Crystal J Jaing; Gabriela G Loots
Journal:  Sci Rep       Date:  2020-03-12       Impact factor: 4.379

10.  The gut microbiome in atherosclerotic cardiovascular disease.

Authors:  Zhuye Jie; Huihua Xia; Shi-Long Zhong; Qiang Feng; Shenghui Li; Suisha Liang; Huanzi Zhong; Zhipeng Liu; Yuan Gao; Hui Zhao; Dongya Zhang; Zheng Su; Zhiwei Fang; Zhou Lan; Junhua Li; Liang Xiao; Jun Li; Ruijun Li; Xiaoping Li; Fei Li; Huahui Ren; Yan Huang; Yangqing Peng; Guanglei Li; Bo Wen; Bo Dong; Ji-Yan Chen; Qing-Shan Geng; Zhi-Wei Zhang; Huanming Yang; Jian Wang; Jun Wang; Xuan Zhang; Lise Madsen; Susanne Brix; Guang Ning; Xun Xu; Xin Liu; Yong Hou; Huijue Jia; Kunlun He; Karsten Kristiansen
Journal:  Nat Commun       Date:  2017-10-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.